Myelodysplastic Syndrome Testing Algorithm

When assessing myelodyplastic syndrome (MDS), the same abnormalities may be identified by chromosome analysis and fluorescence in situ hybridization (FISH) testing. Thus, FISH testing and chromosome analysis should not be ordered simultaneously.

Having trouble viewing the algorithm? PDF fileGo directly to the PDF